Suivre
Eduard Grebe
Eduard Grebe
Vitalant Research Institute
Adresse e-mail validée de vitalant.org - Page d'accueil
Titre
Citée par
Citée par
Année
AIDS conspiracy beliefs and unsafe sex in Cape Town
E Grebe, N Nattrass
AIDS and Behavior 16, 761-773, 2012
1232012
Complexity, difference and identity: An ethical perspective
P Cilliers, R Preiser
Springer Science & Business Media, 2010
942010
Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021.
W Sykes, L Mhlanga, R Swanevelder, TN Glatt, E Grebe, C Coleman, ...
Research Square, 2021
792021
The treatment action Campaign's struggle for AIDS treatment in South Africa: coalition-building through networks
E Grebe
Journal of Southern African Studies 37 (4), 849-868, 2011
652011
Assessment of HIV transfusion transmission risk in South Africa: a 10-year analysis following implementation of individual donation nucleic acid amplification technology …
M Vermeulen, N Lelie, C Coleman, W Sykes, G Jacobs, R Swanevelder, ...
Transfusion, 2018
622018
Development of antibody biomarkers of long term and recent dengue virus infections
EJM Nascimento, JW Huleatt, MT Cordeiro, PMS Castanha, JK George, ...
Journal of virological methods 257, 62-68, 2018
532018
SARS‐CoV‐2 antibody persistence in COVID‐19 convalescent plasma donors: dependency on assay format and applicability to serosurveillance
C Di Germanio, G Simmons, K Kelly, R Martinelli, O Darst, M Azimpouran, ...
Transfusion 61 (9), 2677-2687, 2021
492021
Evaluation of commercially available high-throughput SARS-CoV-2 serologic assays for serosurveillance and related applications
M Stone, E Grebe, H Sulaeman, C Di Germanio, H Dave, K Kelly, ...
Emerging infectious diseases 28 (3), 672, 2022
482022
Estimates of SARS-CoV-2 seroprevalence and incidence of primary SARS-CoV-2 infections among blood donors, by COVID-19 vaccination status—United States, April 2021–September 2022
JM Jones
MMWR. Morbidity and Mortality Weekly Report 72, 2023
402023
Moving towards a reliable HIV incidence test–current status, resources available, future directions and challenges ahead
G Murphy, CD Pilcher, SM Keating, R Kassanjee, SN Facente, A Welte, ...
Epidemiology & Infection 145 (5), 925-941, 2017
392017
Interpreting HIV diagnostic histories into infection time estimates: analytical framework and online tool
E Grebe, SN Facente, J Bingham, CD Pilcher, A Powrie, J Gerber, ...
BMC infectious diseases 19, 1-10, 2019
362019
A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal …
H Huerga, F Shiferie, E Grebe, R Giuliani, JB Farhat, G Van-Cutsem, ...
BMC infectious diseases 17, 1-8, 2017
362017
Estimated hepatitis C prevalence and key population sizes in San Francisco: a foundation for elimination
SN Facente, E Grebe, K Burk, MD Morris, EL Murphy, A Mirzazadeh, ...
PloS one 13 (4), e0195575, 2018
332018
Reinfection by the SARS-CoV-2 Gamma variant in blood donors in Manaus, Brazil
CA Prete Jr, LF Buss, R Buccheri, CMM Abrahim, T Salomon, ...
BMC infectious diseases 22 (1), 127, 2022
322022
Performance of the Bio-Rad Geenius HIV1/2 supplemental assay in detecting “recent” HIV infection and calculating population incidence
SM Keating, R Kassanjee, M Lebedeva, SN Facente, JC MacArthur, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 73 (5), 581-588, 2016
312016
HIV incidence in US first-time blood donors and transfusion risk with a 12-month deferral for men who have sex with men
E Grebe, MP Busch, EP Notari, R Bruhn, C Quiner, D Hindes, M Stone, ...
Blood, The Journal of the American Society of Hematology 136 (11), 1359-1367, 2020
282020
Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in South Africa in March 2022
J Bingham, R Cable, C Coleman, TN Glatt, E Grebe, L Mhlanga, C Nyano, ...
Research square, 2022
252022
Infection staging and incidence surveillance applications of high dynamic range diagnostic immuno-assay platforms
E Grebe, A Welte, J Hall, SM Keating, SN Facente, K Marson, JN Martin, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 76 (5), 547-555, 2017
252017
Selecting COVID‐19 convalescent plasma for neutralizing antibody potency using a high‐capacity SARS‐CoV‐2 antibody assay
E Goodhue Meyer, G Simmons, E Grebe, M Gannett, S Franz, O Darst, ...
Transfusion 61 (4), 1160-1170, 2021
242021
Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for incidence surveillance
JB Sempa, A Welte, MP Busch, J Hall, D Hampton, SM Keating, ...
PLoS ONE 14 (7), e0220345, 2019
242019
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20